نتایج جستجو برای: آزمایش cpt

تعداد نتایج: 71020  

Journal: :Brain research 2006
Elif Kirmizi-Alsan Zubeyir Bayraktaroglu Hakan Gurvit Yasemin H Keskin Murat Emre Tamer Demiralp

Neuropsychological tests target specific cognitive functions; however, numerous cognitive subcomponents are involved in each test. The aim of this study was to decompose the components of two frontal executive function tests, Go/NoGo (GNG) and cued continuous performance task (CPT), by analyzing event-related potentials (ERPs) of 24 subjects both in time and time-frequency domains. In the time ...

Journal: :Cancer research 1986
P J Tofilon C M Vines F L Baker D F Deen W A Brock

The effect of cis-diamminedichloroplatinum(II) (cPt) on sister chromatid exchange (SCE) induction was determined in 13 human primary tumor cell cultures. Primary cultures were derived from surgical specimens of solid tumors composed of a variety of histologies. Three to 16 days after biopsy, depending on the growth rate, cultures were treated with graded concentrations of cPt for 1 h and the SC...

2016
Laura Astolfi Edi Simoni Filippo Valente Sara Ghiselli Stavros Hatzopoulos Milvia Chicca Alessandro Martini

Cisplatin (Cpt) is known to induce a high level of oxidative stress, resulting in an increase of reactive oxygen species damaging the inner ear and causing hearing loss at high frequencies. Studies on animal models show that antioxidants may lower Cpt-induced ototoxicity. The aim of this study is to evaluate the ototoxic effects of two different protocols of Cpt administration in a Sprague-Dawl...

2013
Jean-Paul Bonnefont Michel Colonna Claude Cepanec Jean-Paul Leroux Jean-Marie Saudubray

Reported cases of carnitine palmitoyltransferase II (CPT II) deficiency are characterized only by a muscular symptomatology in young adults although the defect is expressed in extramuscular tissues as well as in skeletal muscle. We describe here a CPT II deficiency associating hypoketotic hypoglycemia, high plasma creatine kinase level, heart beat disorders, and sudden death in a 3-mo-old boy. ...

2014
Joanna Proszek Amit Roy Ann-Katrine Jakobsen Rikke F. Frøhlich Birgitta Ruth Knudsen Magnus Stougaard

Human topoisomerase I (hTopI) is an essential cellular enzyme. The enzyme is often upregulated in cancer cells, and it is a target for chemotherapeutic drugs of the camptothecin (CPT) family. Response to CPT-based treatment is dependent on hTopI activity, and reduction in activity, and mutations in hTopI have been reported to result in CPT resistance. Therefore, hTOPI gene copy number, mRNA lev...

Journal: :Molecular pharmacology 2005
Michal Harel Janice L Hyatt Boris Brumshtein Christopher L Morton Kyoung Jin P Yoon Randy M Wadkins Israel Silman Joel L Sussman Philip M Potter

The anticancer prodrug 7-ethyl-10-[4-(1-piperidino)-1-piperidino-]carbonyloxycamptothecin (CPT-11) is a highly effective camptothecin analog that has been approved for the treatment of colon cancer. It is hydrolyzed by carboxylesterases to yield 7-ethyl-10-hydroxycamptothecin (SN-38), a potent topoisomerase I poison. However, upon high-dose intravenous administration of CPT-11, a cholinergic sy...

1999
DALLAS C. KENNEDY

The CPT symmetry of relativistic quantum field requires the total lifetimes of particles and antiparticles be equal. Detection of p lifetime shorter than τp ∼ > O(10) yr would signal breakdown of CPT invariance, combined with B–violation. Limits on τp inferred from laboratory and cosmic ray measurements range from months to about one Myr, placing lower limits on CPT–violating scales that depend...

Journal: :Molecular cancer therapeutics 2005
Rami G Azrak Jinsheng Yu Lakshmi Pendyala Patrick F Smith Shousong Cao Xia Li William D Shannon Farukh A Durrani Howard L McLeod Youcef M Rustum

The combination of methylselenocysteine and irinotecan (CPT-11) is synergistic against FaDu and A253 xenografts. Methylselenocysteine/CPT-11 increased tumor cure rate to 100% in FaDu and to 60% in A253. In this study, the effect of methylselenocysteine on pharmacokinetic and pharmacogenetic profiles of genes relevant to CPT-11 metabolic pathway was evaluated to identify possible mechanisms asso...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2008
Puja Sapra Hong Zhao Mary Mehlig Jennifer Malaby Patricia Kraft Clifford Longley Lee M Greenberger Ivan D Horak

PURPOSE Clinical development of SN38, the active metabolite of camptothecin-11 (CPT-11), has been hampered due to its poor solubility. We have developed a novel polymer-drug conjugate, EZN-2208, made by linking SN38 with a multiarm polyethylene glycol via a glycine linker. EXPERIMENTAL DESIGN The in vitro cytotoxicity of EZN-2208 was tested using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxym...

2012
Touseef Amna M Shamshi Hassan Ki-Taek Nam Yang You Bing Nasser AM Barakat Myung-Seob Khil Hak Yong Kim

The aim of this study was to fabricate camptothecin/iron(III) oxide (CPT/Fe₂O₃)-loaded poly(D,L-lactide-co-glycolide) (PLGA) composite mats to modulate the CPT release and to improve the structural integrity and antitumor activity of the released drug. The CPT/Fe₂O₃-loaded PLGA ultrafine fibers were prepared for the first time by electrospinning a composite solution of CPT/Fe₂O₃ and neat PLGA (...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید